Drug recall · August 12, 2026
Dicyclomine Hydrochloride Capsules recall
Why: shortfill; reports of empty capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
- Lots / codes
Batch # DMC125018A, Exp Date: 07/2027.
- Quantity
- 6,408 bottles distributed to market
- Company
- Aurobindo Pharma USA Inc, East Windsor, NJ
- Distribution
- US Nationwide.
- Initiated
- July 23, 2026 · Voluntary: Firm initiated
- Classified
- August 4, 2026
- Reported
- August 12, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dicyclomine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.